R
Roberto Di Donato
Researcher at University of Bologna
Publications - 10
Citations - 202
Roberto Di Donato is an academic researcher from University of Bologna. The author has contributed to research in topics: Hepatitis C & Viral hepatitis. The author has an hindex of 6, co-authored 10 publications receiving 175 citations.
Papers
More filters
Journal ArticleDOI
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?
Maurizio Biselli,Stefano Gitto,Annagiulia Gramenzi,Roberto Di Donato,Lucia Brodosi,Matteo Ravaioli,Gian Luca Grazi,Antonio Daniele Pinna,Pietro Andreone,Mauro Bernardi +9 more
TL;DR: In conclusion, MELD‐sodium and integrated MELD were the best prognostic models to predict drop‐out rates among patients awaiting LT.
Journal ArticleDOI
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study
Fabio Piscaglia,Veronica Salvatore,L. Mulazzani,Vito Cantisani,Antonio Colecchia,Roberto Di Donato,Cristina Felicani,Alessia Ferrarini,N. Gamal,Valentina Grasso,Giovanni Marasco,Elena Mazzotta,Federico Ravaioli,Giacomo Ruggieri,Ilaria Serio,Joules Fabrice Sitouok Nkamgho,Carla Serra,Davide Festi,Cosima Schiavone,Luigi Bolondi +19 more
TL;DR: The present results showed only moderate concordance of the majority of elastography machines with the Fibroscan results, preventing the possibility of the immediate universal adoption of fibroscan thresholds for defining liver fibrosis staging for all new machines.
Journal ArticleDOI
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
Elisabetta Loggi,Stefano Gitto,Silvia Galli,Mario Minichiello,Fabio Conti,E. Grandini,A. Scuteri,Giovanni Vitale,Roberto Di Donato,Carmela Cursaro,Giuliano Furlini,Pietro Andreone +11 more
TL;DR: A past HBV infection seems not to be a condition predisposing to HBV reactivation and, in HBsAg-positive subjects not in suppressive treatment with nucleos(t)ide analogs, regular monitoring of HBV-DNA during and after DAA treatment should be considered.
Journal ArticleDOI
Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness
Veronica Salvatore,Alberto Borghi,Eugenia Peri,Antonio Colecchia,Silvia Li Bassi,L. Montrone,Roberto Di Donato,Fabio Conti,Cristina Crespi,Davide Festi,Mauro Bernardi,Pietro Andreone,Luigi Bolondi +12 more
TL;DR: Hepatic and splenic arteries resistance indexes and the hepatic veins waveform pattern assessed by Doppler ultrasound may provide information similar to that of Transient Elastography in hepatitis C related chronic liver disease.
Journal ArticleDOI
Serum SCCA-IgM as a Predictor of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
Daniela Buccione,G. Fatti,Andrea Gallotta,Elisabetta Loggi,Roberto Di Donato,Lilia Testa,Carlo Saitta,V. Santi,Antonio Di Micoli,Virginia Erroi,Marta Frigerio,Valentina Fazio,Antonino Picciotto,Alessandra Biasiolo,Francoise Degos,Patrizia Pontisso,Giovanni Raimondo,Franco Trevisani +17 more
TL;DR: SCCA-IgM serum measurement could permit implementation of a two step surveillance: an initial serological surveillance, based on the annual monitoring of this biomarker, and the conventional surveillance by semiannual US when SCCA+ve cirrhotic patients at low HCC risk becomes >200 AU/mL.